Sept. 9, 2025 - Epoch Times
01:29
| 
| Time | Text |
|---|---|
| Well we discovered this bifidobacteria was really the beginning. | |
| It was the beginning, and then when you when we looked at that kid with an N of one of autism, that we got approval after, you know, in the midst of COVID, and we discovered if I give him a neurotypical sibling that has a diversity, that has good resilient microbes that have you know allowed herself not to have autism, but yet the boy has autism, then that sibling might be the answer for that kid. | |
| And what we noticed with this sibling is that the kid had one group of microbes that the sibling didn't have. | |
| So we picked that sibling. | |
| We didn't pick the other ones because they had some of the same microbes as the kid with autism. | |
| Are they predisposed to going into autism? | |
| Who knows? | |
| But we picked that one sibling, and that one sibling became the donor. | |
| And what we discovered with that was that there was a ref there was a refloralization. | |
| And the refloralization process is really an engraftment of microbes to mimic, to look like the sibling, to look like the donor. | |
| And one of the things we discovered was that bifidobacteria increasing. | |
| Now, whether it was because we suppressed that toxic bacteria and allowed the gut to kind of rest and give it diversity and therefore the good bacteria starts flourishing. | |
| But that case was really the N of one that first of all made me say, I need to see more. |
Export Selection